10:00 - 11:00
Room: Lomond Auditorium (Loch Suite)

IP22: HOW CAN WE ASSESS THE VALUE OF NEW ANTIBIOTICS?

Moderator:

Chris Henshall, PhD, Independent Consultant and Visiting Fellow, Office of Health Economics, London, UK, UK

Panelists:

Alec Morton, PhD, Professor of Management Science, Department of Management Science, Strathclyde Business School, University of Strathclyde, Glasgow, Scotland, UK

Douglas Lundin, PhD, Chief Economist, TLV, Stockholm, Sweden

Adrian Towse, MA, MPhil, Director, Office of Health Economics, London, UK